LOZAPINE 25 MG

País: Israel

Idioma: inglés

Fuente: Ministry of Health

Ingredientes activos:

CLOZAPINE

Disponible desde:

TARO INTERNATIONAL LTD, ISRAEL

Código ATC:

N05AH02

formulario farmacéutico:

TABLETS

Composición:

CLOZAPINE 25 MG

Vía de administración:

PER OS

tipo de receta:

Required

Fabricado por:

GENTHON B.V.

Grupo terapéutico:

CLOZAPINE

Área terapéutica:

CLOZAPINE

indicaciones terapéuticas:

Treatment of resistant schizophrenic patients who are non-responsive to, or intolerant of classic neuroleptics.Reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state.Suicidal behavior refers to actions by a patient that put him/herself at risk for death

Fecha de autorización:

2020-04-30

Información para el usuario

Lozapine – Notification 03.21 - ENG
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS' REGULATIONS
(PREPARATIONS) - 1986
This medicine is dispensed with a doctor's prescription only
LOZAPINE 25 MG
TABLETS
LOZAPINE 100 MG
TABLETS
Active ingredient and quantity:
Active ingredient and quantity:
Each tablet contains:
Each tablet contains:
clozapine 25 mg
clozapine 100 mg
Inactive ingredients and allergens: See section 2 under ‘Important
information about some of this medicine’s ingredients’ and section
6
‘Additional information’.
PREPARATION DISPENSING INSTRUCTIONS:
DURING THE FIRST 18 WEEKS:
PERFORM A BLOOD TEST ONCE A WEEK DURING THE FIRST 18 WEEKS.
THE COMMUNITY PHARMACY WILL DISPENSE THE MEDICINE FOR ONE WEEK
OF TREATMENT ONLY, ACCORDING TO A DOCTOR'S PRESCRIPTION, PROVIDED
THAT IT CARRIES THE STAMP:
“WHITE BLOOD CELL TEST WAS PERFORMED, AND THE RESULTS ARE NORMAL”.
STARTING FROM WEEK 19 OF TREATMENT:
A BLOOD TEST MUST BE PERFORMED AT LEAST ONCE A MONTH.
THE COMMUNITY PHARMACY WILL DISPENSE THE MEDICINE FOR ONE MONTH
OF TREATMENT ONLY, ACCORDING TO A DOCTOR'S PRESCRIPTION, PROVIDED
THAT IT CARRIES THE STAMP:
“WHITE BLOOD CELL TEST WAS PERFORMED, AND THE RESULTS ARE NORMAL”.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE. This leaflet contains concise information about this
medicine.
If you have any further questions, consult your doctor or pharmacist.
This medicine has been prescribed to treat your illness. Do not pass
it
on to others. It may harm them, even if it seems to you that their
illness
is similar to yours.
Before starting treatment with Lozapine, blood tests must be performed
to
make sure that you can take the medicine.
1.
WHAT IS THIS MEDICINE INTENDED FOR?
Lozapine is used for treatment in resistant schizophrenic patients who
are
non-responsive to, or intolerant of other antipsychotic medicines.
The medicine is also intended for reducing the risk of recurrent
suicidal
behaviour in patients with schizophrenia or schizoaffective disorder
who
are long-term ris